# A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers

> **NCT07745907** · PHASE1 · RECRUITING · sponsor: **Amgen** · enrollment: 28 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** AMG 691

## Key facts

- **NCT ID:** NCT07745907
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-07
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745907, "A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07745907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*